The Importance of Suppressing Pathological Periostin Splicing Variants with Exon 17 in Both Stroma and Cancer
These findings suggest that it is important to suppress POSTN exon 17 in both stroma and cancer. Antibody targeting POSTN exon 17 may be a therapeutic candidate for breast cancer.
Authors
- Yoshiaki Taniyama (ORCID: https://orcid.org/0000-0002-6057-7982)
- Naruto Katsuragi
- Ryuichi Morishita (ORCID: https://orcid.org/0000-0002-8855-0730)
- Nobutaka Koibuchi
- Yasuo Tsunetoshi
- Yuko Kanemoto
- Fumihiro Sanada (ORCID: https://orcid.org/0000-0002-3728-5607)
- Shoji Ikebe
- Kenzo Shimazu (ORCID: https://orcid.org/0000-0002-0837-2357)
- Kōichi Yamamoto (ORCID: https://orcid.org/0000-0003-0107-9315)
- Kana Shibata
Institutions
- Osaka Dental University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Cells
- Published
- 2024-08-23
- DOI
- https://doi.org/10.3390/cells13171410
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science